drugset / Trial / NCT01337739

Use of Dexmedetomidine for Deep Sedation in Patients Undergoing Outpatient Hysteroscopic Surgery

NCT01337739 ↗

Terminated 8 enrolled Northwestern University
RandomizedParallel-groupTriple-blindTreatment

Summary

Patients undergoing deep sedation for outpatient procedures typically receive a combination of benzodiazepines, propofol, and opioids. Side effects of such anesthetics include respiratory depression, nausea and vomiting, and urinary retention, with resultant extended hospital stays and unanticipated admission. The use of dexmedetomidine for deep sedation may increase patient safety by maintaining respiratory drive, while providing sedation, hypnosis, and analgesia. Furthermore, patients may experience decreased pain, nausea, and time to discharge in the PACU, especially if dexmedetomidine decreases the requirement of other drugs such as opioids. The hypothesis of this study is administration of dexmedetomidine during deep sedation for ambulatory hysteroscopic surgery will result in a 50% reduction of intraoperative opioid compared to sedation with propofol.

Timeline

Start
2010-10
Primary completion
2012-04
Completion
2012-04

Outcome

Outcome not reported

Stopped: “The study drug delayed time of discharge which is clinically impracticable.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.2 g/kg —
Comparator Dexmedetomidine Other / unclassified 1.5 g/kg —

Indications

No indication recorded.